The investment vehicle is backed by major pharma companies like Novartis, Otsuka and the Chiesi Group, along with Irvine-based medical device maker Masimo and the venture arm of Chinese insurance firm Ping An.
The company raised an oversubscribed Series A round in November and recently made a final close for the round, adding two strategic investors to investors that include companies such as GIS Strategic Ventures, Heitkamp & Thumann Group, and P5 Health Ventures.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Measuring lung function, enhancing fetal monitoring and tissue engineering took the top three prizes at second edition of Impact Pediatric Pitch. But of the digital health technologies on display, machine learning was a big theme.
Investors included Blue Cross Blue Shield of Massachusetts, Bioadvance, Three Leaf Ventures — an affiliate of the Broe Group, Swanhill Capital and StartUp Health through its digital health syndicate.
CEO Melissa Manice said the thinking behind its device was this: "What if we built a clinical grade medical device that could serve as a barometer for lung function?'